Literature DB >> 15637712

Large deletion involving the 5'-UTR in the spastin gene caused mild phenotype of autosomal dominant hereditary spastic paraplegia.

Hiroshi Iwanaga1, Akira Tsujino, Susumu Shirabe, Hiroto Eguchi, Naomi Fukushima, Norio Niikawa, Koh-Ichiro Yoshiura, Katsumi Eguchi.   

Abstract

Hereditary spastic paraplegia (HSP) due to mutations in the spastin gene (SPG4) located to 2p22-p21 is the most common form of autosomal dominant (AD) HSP. We performed PCR-based direct sequencing of SPG4, followed by a linkage analysis and subsequent Southern blot analysis in large Japanese kindred where 20 of 33 members were evaluated neurologically, and consequently 6 were affected with HSP. Clinical evaluation showed that the mean age at disease onset of the patients was older and the disability was less severe than those of previously reported typical patients with SPG4 mutations. Direct sequencing of genomic DNA and RT-PCR product did not show a SPG4 mutation despite of a strong linkage to the SPG4 locus at 2p. Southern blot analysis suggested a deletion involving the 5'-UTR of SPG4. Further sequence analysis confirmed a heterozygous 2307-bp deletion spanning from the 5'-UTR to intron 1 of SPG4. The results suggested that transcription of the mutated allele starts from an authentic initiation site, but lacks an authentic translational start site of exon 1 because of a deficient splice donor site and coding region. The abnormal transcripts may result in rapid RNA decay. The novel refractory mutation we identified widens the spectrum of SPG4 mutations. These findings suggest that structural genomic abnormalities of SPG4 are more frequent than expected, and this explains previously reported cases more feasibly in which SPG4 mutations were failed to be identified but the disease was linked to 2p. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637712     DOI: 10.1002/ajmg.a.30510

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  6 in total

1.  The Alu-rich genomic architecture of SPAST predisposes to diverse and functionally distinct disease-associated CNV alleles.

Authors:  Philip M Boone; Bo Yuan; Ian M Campbell; Jennifer C Scull; Marjorie A Withers; Brett C Baggett; Christine R Beck; Christine J Shaw; Pawel Stankiewicz; Paolo Moretti; Wendy E Goodwin; Nichole Hein; John K Fink; Moon-Woo Seong; Soo Hyun Seo; Sung Sup Park; Izabela D Karbassi; Sat Dev Batish; Andrés Ordóñez-Ugalde; Beatriz Quintáns; María-Jesús Sobrido; Susanne Stemmler; James R Lupski
Journal:  Am J Hum Genet       Date:  2014-07-24       Impact factor: 11.025

2.  Partial SPAST and DPY30 deletions in a Japanese spastic paraplegia type 4 family.

Authors:  Shiroh Miura; Hiroki Shibata; Hiroshi Kida; Kazuhito Noda; Takayuki Toyama; Naoka Iwasaki; Akiko Iwaki; Mitsuyoshi Ayabe; Hisamichi Aizawa; Takayuki Taniwaki; Yasuyuki Fukumaki
Journal:  Neurogenetics       Date:  2010-09-22       Impact factor: 2.660

3.  Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia.

Authors:  Christel Depienne; Estelle Fedirko; Sylvie Forlani; Cécile Cazeneuve; Pascale Ribaï; Imed Feki; Chantal Tallaksen; Karine Nguyen; Bruno Stankoff; Merle Ruberg; Giovanni Stevanin; Alexandra Durr; Alexis Brice
Journal:  J Med Genet       Date:  2006-11-10       Impact factor: 6.318

4.  Alu-specific microhomology-mediated deletion of the final exon of SPAST in three unrelated subjects with hereditary spastic paraplegia.

Authors:  Philip M Boone; Pengfei Liu; Feng Zhang; Claudia M B Carvalho; Charles F Towne; Sat Dev Batish; James R Lupski
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

5.  Mechanistic basis of an epistatic interaction reducing age at onset in hereditary spastic paraplegia.

Authors:  Timothy Newton; Rachel Allison; James R Edgar; Jennifer H Lumb; Catherine E Rodger; Paul T Manna; Tania Rizo; Zacharias Kohl; Anders O H Nygren; Larissa Arning; Rebecca Schüle; Christel Depienne; Lisa Goldberg; Christiane Frahm; Giovanni Stevanin; Alexandra Durr; Ludger Schöls; Beate Winner; Christian Beetz; Evan Reid
Journal:  Brain       Date:  2018-05-01       Impact factor: 13.501

6.  Novel SPAST deletion and reduced DPY30 expression in a Spastic Paraplegia type 4 kindred.

Authors:  Loretta Racis; Eugenia Storti; Maura Pugliatti; Virgilio Agnetti; Alessandra Tessa; Filippo M Santorelli
Journal:  BMC Med Genet       Date:  2014-04-01       Impact factor: 2.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.